Bilateral triple-negative invasive breast cancer with a BRCA2 mutation, and glioblastoma: A case report and literature review

5Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Breast cancer is the second leading cause of death among women in North America. Glioblastoma is the most common primary malignant central nervous system tumor in adults. The majority of hereditary breast cancers are associated with deleterious mutations in the BRCA1 and BRCA2 genes. Although few case reports have described the incidence of glioblastoma in patients previously diagnosed with breast cancer, any association between BRCA2 mutations and glioblastoma has not been demonstrated to date. Herein, we report a woman who is a car rier of a familial BRCA2 mutation, and was previously diagnosed with triple-negative breast cancer (TNBC) and subsequently with a second primary TNBC and glioblastoma. Further investigation is required to define the possible relationship between these two aggressive malignances and the BRCA2 mutation, which might be critical for the proper management and treatment of this disease.

Cite

CITATION STYLE

APA

Raufi, A., Alsharedi, M., Khelfa, Y., & Tirona, M. (2017, March 1). Bilateral triple-negative invasive breast cancer with a BRCA2 mutation, and glioblastoma: A case report and literature review. Journal of Breast Cancer. Korean Breast Cancer Society. https://doi.org/10.4048/jbc.2017.20.1.108

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free